A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

Conditions:   NK/T Cell Lymphoma;   Vascular Immunomother T Cell Lymphoma;   Non-Hodgkin Lymphoma Intervention:   Drug: GNC-038 Sponsors:   Sichuan Baili Pharmaceutical Co., Ltd.;   SystImmune Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials